Federal Judge Throws Out Promega's Case Against Roche
Claim of Fraud is Rejected for Second Time
The U.S. District Court for the Eastern District of Virginia announced Monday it had again dismissed a case filed by the Promega Corporation against Hoffmann-La Roche Inc (Roche) and Applied Biosystems (ABI), rejecting Promega's attempt to claim that Roche and ABI committed fraud against the U.S. Government.
Federal Judge Claude M. Hilton ruled that Promega had failed to state a fraud claim against Roche, rejecting for a second time Promega's claims that Roche had committed fraud by enforcing patents used to perform the Nobel Prize-winning Polymerase Chain Reaction (PCR) technology, widely used by health and law enforcement officials.
"We were baffled by this case from the beginning, because Promega failed to identify any false statements made by Roche to the Government, or any false charges ever submitted by Roche," said Ray Mullady of Orrick, Herrington & Sutcliffe LLP, who is representing Roche in the matter. "We are pleased that the Court has once again dismissed Promega's groundless litigation."
Promega's case, filed under the False Claims Act, was first dismissed by Judge Hilton in June, when he determined that Promega had not been able to plead the basic facts required to show a violation of law. Promega's amended complaint, filed in July, offered no new information and recycled those claims already rejected by the Virginia court.
In May, the U.S. District Court for the Northern District of California rejected similar claims made by Promega, declining to find Roche's portfolio of PCR patents unenforceable. Promega pursued the Virginia case in an effort to pressure Roche into settling the case in California, in which Roche has sued Promega for infringing the fundamental patents on PCR, according to attorneys for Roche. The U.S. Department of Justice expressly declined to join Promega in pursuing the False Claims case.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
